|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 1/00 | (2006.01) |
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 1373300 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02727437.2 |
| Date of filing the European patent application | 2002-03-19 | |
| (97) | Date of publication of the European application | 2004-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2009-05-20 |
| (46) | Date of publication of the claims translation | 2009-09-25 |
| (86) | Number | PCT/EP2002/003034 |
| Date | 2002-03-19 |
| (87) | Number | WO 2002/074784 |
| Date | 2002-09-26 |
| (30) | Number | Date | Country code |
| 01106891 | 2001-03-20 | EP |
| (72) |
SELVE, Norma, DE
|
| (73) |
UCB Pharma GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Peptidų klasės junginių naujas panaudojimas ne neuropatinių uždegiminių skausmų gydymui |
| NOVEL USE OF A PEPTIDE CLASS OF COMPOUND FOR TREATING NON NEUROPATHIC INFLAMMATORY PAIN |
| Payment date | Validity (years) | Amount | |
| 2011-02-09 | 10 | 800.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2012-03-19 |